Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children.
about
Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of ViewPulmonary hypertension: diagnostic and therapeutic challengesDrug treatment of pulmonary hypertension in childrenPulmonary Hypertension in Children.Pediatric pulmonary arterial hypertension.Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgeryProgress in the diagnosis and management of pulmonary hypertension in children.Pulmonary hypertension in bronchopulmonary dysplasiaAcute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials)Current challenges in pediatric pulmonary hypertension.Current and advancing treatments for pulmonary arterial hypertension in childhood.Treatment of pulmonary arterial hypertension in children.Diagnostic Approach to Pulmonary Hypertension in Premature Neonates.Inhaled treprostinil via the Tyvaso Inhalation System through a tracheostomy.Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.
P2860
Q26749283-73F8BE90-5991-4A6A-BC51-053E6D7A8FA6Q26796434-A4ACA556-E2F9-47D3-9EB2-C43709BD3500Q26996078-65C9C47A-AE20-4F2B-ACFB-354B19AC1BA3Q30248871-D0EB8579-F515-4515-9E83-59A2EFCF2ED1Q33163446-C87FE215-7EC6-49B7-BD60-1097563FF351Q33805945-167BEFFF-DEF9-4E58-B332-59F82162210FQ34479289-52AB3AB5-D05F-49A5-984A-09FDF73624C3Q35731631-7F82F339-A37F-4EC6-AA12-E45C119ABE6EQ36718346-F0183CF3-E49E-4B0C-BEE2-B2C04E832CDCQ36763080-CE305222-AA2A-483D-8681-6100E242E878Q37531525-9C7E010E-E698-4A22-81F3-6FFEF85134EBQ37540613-C519F4F9-95B9-4279-BBBD-23AE8060BA6AQ38232339-11823EEA-D313-459B-98CA-CA0B26D41E3BQ38341953-0CD049EC-EBDD-49F5-AF3A-F23622D773B2Q41671339-4EDADD6E-AEE4-42A7-9428-04B7A99F42FEQ41742567-2B0B20B7-C645-431C-B4A9-0D34EE96CF91Q50672722-1B30D50E-5DE1-4946-B021-9EF95F5F56AAQ55001904-774BAAB0-CECA-4093-8B79-D75B9DD00BA5
P2860
Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effectiveness and safety of in ...... rial hypertension in children.
@ast
Effectiveness and safety of in ...... rial hypertension in children.
@en
type
label
Effectiveness and safety of in ...... rial hypertension in children.
@ast
Effectiveness and safety of in ...... rial hypertension in children.
@en
prefLabel
Effectiveness and safety of in ...... rial hypertension in children.
@ast
Effectiveness and safety of in ...... rial hypertension in children.
@en
P2093
P2860
P1476
Effectiveness and safety of in ...... erial hypertension in children
@en
P2093
Dunbar D Ivy
Elizabeth Coleman
Jason Kerstein
Michelle Calderbank
Shinichi Takatsuki
Usha Krishnan
P2860
P304
P356
10.1016/J.AMJCARD.2012.07.037
P407
P577
2012-08-21T00:00:00Z